Consistent with this, Sestrin2 overexpression has been reported to attenuate cancer‐induced bone pain by activating the AMPK/PGC‐1α axis, which promotes mitochondrial biogenesis and suppresses neuroinflammation [65]. Here, PPARGC1A is linked to cancer.